Humana Inc.

HUM Healthcare Healthcare Plans

Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

413.16 19.04 −4.41%
Market cap
$51.9B
P/E
38.8×
Fwd P/E
42.9×
Dividend yield
0.86%
F-score
6/9
Altman Z
4.66
Beneish M
−2.29
Dividend safety
61/100

Humana Inc. (HUM) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Humana Inc. (HUM) trades at a P/B ratio of 2.6×. Over the past ten years it has ranged from 1.1× (March 2026) to 4.6× (November 2018); the current reading is higher than 28% of that period. That is in line with the Healthcare Plans industry median of 2.6× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 1.7× (6.49%)
FY2024 1.9× (47.87%)
FY2023 3.6× (13.32%)
FY2022 4.1× 11.05%
FY2021 3.7× (6.17%)
FY2020 4.0× (3.21%)
FY2019 4.1× 5.30%
FY2018 3.9× 4.92%
FY2017 3.7× 33.73%
FY2016 2.8× 7.13%

Quarterly newest first

Period P/B ratio Change
Jun 2026 2.5× 121.10%
Mar 2026 1.1× (35.67%)
Dec 2025 1.7× 3.29%
Sep 2025 1.7× 4.54%
42 more quarters

Against its own ten years

Low 1.1× High 4.6×
Ten-year median 3.2×
Current reading's percentile 28

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on HUM